Max Robotics — Global Service Robot Directory + US Certification

About

Christopher L. Coogan is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of minimally invasive kidney cancer surgery. His primary research focus is the advancement of single-port robotic surgery, particularly for complex procedures like partial nephrectomy and radical nephroureterectomy. Coogan’s major contributions include demonstrating the safety, feasibility, and potential advantages of single-port over traditional multi-port robotic approaches, as evidenced by his 2024 propensity score-matched analysis (30 citations) and his implementation protocol at a large academic center (17 citations). He has also provided a critical 5-year update on minimally invasive radical nephroureterectomy (15 citations), the gold-standard treatment for non-metastatic upper tract urothelial cancer, detailing evolving techniques and outcomes. His innovative work on the lower anterior approach for single-port partial nephrectomy, supported by video analysis, further highlights his commitment to refining surgical methods. With a growing citation impact, Coogan is establishing himself as a key figure in the transition toward less invasive, more precise urologic oncology, offering patients reduced morbidity without compromising oncologic efficacy.